Amneal Pharmaceuticals, Inc. AMRX
21.12 USD -0.27 (-1.26%)
Regular-session close
21.78 +0.66 +3.15%
After hours · Nov 20, 6:11 PM ET
21.07 Day range 21.70
11.52 52-week range 21.88
- YTD
- +67.62%
- 1 year
- +83.33%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 3.02B | 2.79B | 2.39B | 2.21B | 2.09B | |
| 1.11B | 1.02B | 820.57M | 784.71M | 768.97M | |
| 394.10M | 249.33M | 204.37M | -94.20M | 152.92M | |
| 72.06M | -116.89M | -83.99M | -129.99M | 10.62M | |
| 0.22 | -0.38 | -0.48 | -0.86 | 0.07 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 310.87M | 118.42M | 99.11M | 35.23M | 256.74M | |
| 3.68B | 3.50B | 3.47B | 3.80B | 3.94B | |
| 3.75B | 3.61B | 3.45B | 3.62B | 3.57B | |
| 2.69B | 2.59B | 2.75B | 2.85B | 2.88B | |
| -70.79M | -109.27M | 19.78M | 298.42M | 360.34M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 339.99M | 295.10M | 345.58M | 65.10M | 241.82M | |
| -112.26M | -63.00M | -69.19M | -174.31M | -194.18M | |
| -31.53M | -211.79M | -212.57M | -106.62M | -138.12M | |
| -96.75M | -60.34M | -46.80M | -48.80M | -50.94M | |
| 194.52M | 19.31M | 63.88M | -221.51M | -90.38M |
